N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride,
PJ 34,
PJ-34,
PJ34,
PJ34,
344458-19-1,
pj-34,
N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE,
CHEMBL372303,
P34,
2-(dimethylamino)-N-(6-oxo-5H-phenanthridin-2-yl)acetamide,
2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide,
Acetamide, N-(5,6-dihydro-6-oxo-2-phenanthridinyl)-2-(dimethylamino)-,
UYJZZVDLGDDTCL-UHFFFAOYSA-N,
PJ34(free base),
1xk9,
SCHEMBL422317,
AC1L1J45,
ZINC8960,
BDBM27497,
CTK1B7701,
Ibrutinib (PCI32765 pound(c),
HMS3651B06,
BCP07990,
2662AH,
HY-13688A,
AKOS030229047,
CS-1463,
DB08348,
SB19292,
NCGC00370866-10,
AJ-08322,
BC600341,
DA-42692,
AB0109995,
FT-0722456,
SW219891-2,
W-5671,
BRD-K11853856-003-01-3,
2-(dimethylamino)-N-(5,6-dihydro-6-oxophenanthridin-2yl)acetamide,
2-Dimethylamino-N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-acetamide,
N-(6-oxo-5,6-dihydro- phenanthridin-2-yl)-N,N-dimethylacetamide,
N-(5,6-Dihydro-6-oxo-2-phenanthridinyl)-2-(dimethylamino)-acetamide,
N~2~,N~2~-dimethyl-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)glycinamide,
PJ34 hydrochloride,
D04WDX,
PJ 34,
CID4858,
C17H17N3O2,
A3729,
A4159,
A15215,
C434926,
2-dimethylamino-N-(6-oxo-5H-phenanthridin-2-yl)-acetamide,
2-(5,6-dihydro-6-oxophenanthridin-2-yl)-N,N-dimethylacetamide,
N-(Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide,
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride,
344458-15-7,
79775-19-2,